Quick Facts
  • wavy circle icon with check mark inside
    Pleural Mesothelioma
    Lung Cancer
    Video-Assisted Thoracoscopic Surgery
    Pleurectomy and Decortication Surgery
  • certificate with a ribbon icon below
    General Surgery
    Thoracic Surgery
  • magnifying glass with heart icon
    Thoracic Surgery
  • gender symbols interlocked icon
  • chat box with different language translations icon
    English, Spanish, Hebrew, Arabic

About Dr. Abraham Lebenthal

Dr. Abraham Lebenthal is passionate about his work with malignant mesothelioma patients. He is a respected thoracic doctor at Assuta Medical Center in Ashdod, Israel.

Before moving to Israel, Lebenthal was at the Dana-Farber Cancer Institute in Boston where he used his extensive experience to perform the most aggressive surgeries for pleural mesothelioma. He also served as a professor at Harvard Medical School for nearly 12 years.

Lebenthal was recruited to Dana-Farber and trained by mesothelioma treatment pioneer and thoracic surgeon Dr. David Sugarbaker. He formerly worked at the VA Boston Healthcare System.

In addition to mesothelioma, his clinical interests include lung cancer, mediastinal tumors, thymic tumors and esophageal cancer. He has experience with advanced laparoscopy and therapeutic endoscopy techniques.

When it comes to mesothelioma, Lebenthal believes in tailoring treatment for every individual, being aggressive with his approach, and “pushing the envelope” to find solutions.

Lebenthal credits his military training for much of the success and the passion he exhibits as a thoracic surgeon.

He served active duty as a battalion physician in an elite infantry unit within the Israeli Army after his graduation from medical school. It was there he received a Letter of Distinction for Bravery after evacuating combat soldiers under fire.

“One of the things you learn in the military is, there is no such thing as ‘I can’t.’ You learn to make good decisions,” he said. “You learn to take responsibility and ownership. And you better have precise execution. It’s the same in medicine.”

That training also attracted Lebenthal to mesothelioma, a rare and aggressive cancer that has hit a disproportionate number of veterans exposed to asbestos, stemming from the military’s use of contaminated products.

“I have a deep admiration and respect for people who served in the military. It’s part of my background,” he said. “As in war, we don’t leave our brothers behind.”

Dr. Lebenthal’s Role as Medical Reviewer on Asbestos.com

Lebenthal’s experience with pleural mesothelioma, work with veterans and clinical trial experience qualify him as a contributor and reviewer for The Mesothelioma Center at Asbestos.com. His expertise ensures the pleural mesothelioma topics and content on Asbestos.com meet the latest medical and scientific standards.

Lebenthal has served as a reviewer and editorial board member on reputable medical journals, including Artificial Intelligence Surgery.

Specialties of Dr. Abraham Lebenthal

Experience and Medical Education

  • Assuta Medical Center
  • Dana-Farber Cancer Institute
  • Brigham and Women’s Hospital
  • Good Samaritan Medical Center
  • VA Boston Healthcare System
  • Fox Chase Cancer Center
  • Harvard Medical School (Instructor)
  • Mount Sinai Medical Center (Residency)
  • Hebrew University Medical Center (Residency)
  • Brigham and Women’s Hospital (Fellowship)
  • Hebrew University Hadassah Medical School (M.D.)

Awards and Recognition

  • Letter of Distinction for Bravery, Israeli Army
  • Golden Heart Award, VA Boston Healthcare System
  • Compassionate Doctor Award
  • Patient’s Choice 5th Anniversary Award

Mesothelioma Clinical Trials Under Abraham Lebenthal, M.D.

  • A multicenter phase II study of toxicity issues involving the combination of neoadjuvant chemotherapy and modulated radiation therapy in combination with pleurectomy and decortication surgery.
Specialist consultation with a patient
Find a Mesothelioma Cancer Center
Access top mesothelioma cancer centers that have experience treating this rare disease.

Publications of Dr. Abraham Lebenthal

  • Ijsseldijk, M. et al. (2019). Survival After Stereotactic Body Radiation Therapy for Clinically Diagnosed or Biopsy-Proven Early-Stage NSCLC: A Systemic Review and Meta-Analysis. Journal of Thoracic Oncology.
  • Siegert, C. et al. (2017). Open access phone triage for veterans with suspected malignant pleural mesothelioma. Journal of Surgical Research.
  • Fisichella, M., Lebenthal, A. & Jalilvand, A. (2015). Diagnostic Evaluation of Achalasia: From the Whalebone to the Chicago Classification. World Journal of Surgery.
  • Paul, S. et al. (2007). Primary Ewing sarcoma invading the heart: resection and reconstruction. Journal of Cardiovascular Surgery.